Starting opioid addiction treatment in the ED is cost-effective

August 16, 2017, Yale University

The most cost-effective treatment for people with untreated opioid addiction who visit the emergency department (ED) is buprenorphine, a medication to reduce drug cravings and withdrawal, say Yale researchers. Their study found that among patients who came to the ED, the ED-initiated medication strategy was most likely to be cost-effective compared to referral alone or a brief intervention with facilitated referral, the researchers said.

The study was published in the journal Addiction.

Nationally, only about one in five individuals who needed treatment for addiction received treatment in the past year, and fewer received the most effective treatments, such as buprenorphine. Yet studies have shown that treating individuals with such medications is effective. In an earlier analysis of this study, Yale researchers found that when patients are screened for opioid addiction, receive ED-initiated buprenorphine, and a referral for ongoing treatment, the treatment was more effective than a standard referral or brief intervention with referral.

In this new analysis, the Yale team compared the relative cost and value of the three approaches for individuals screening positive for opioid addiction: referral alone, brief intervention with facilitated referral, and ED-initiated buprenorphine. They compared the estimated costs of for patients over the 30 days following their ED visit. Those costs included ED care, , inpatient and outpatient costs, and medications. The research team defined effectiveness as engagement in addiction treatment at 30 days.

The researchers found that the ED-initiated buprenorphine was the most likely to be cost-effective, with a mean cost of $1,752 compared with $1,805 for brief intervention and $1,977 for referral. The ED-initiated buprenorphine group was nearly twice as likely to be enrolled in treatment, and used illicit opioids for fewer days, during the 30 days after the ED visit.

"On average, the costs were lowest in the ED-initiated buprenorphine group," said first author Susan Busch, professor at the Yale School of Public Health. "Those patients did not use additional health care resources, but had better outcomes."

"We were excited to learn that not only was ED-initiated more effective in engaging patients in treatment, but it was cost-effective, said senior author Gail D'Onofrio, M.D. "All insurance payers and healthcare systems should be interested in these results."

"We know that the opioid epidemic has devastating consequences for individuals, yet many people are not in ," said Busch. "This is one high-value, effective way to get people the help they need."

Explore further: Patients with opioid addiction benefit from treatment initiated in ED

Related Stories

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Emergency department treatment for opioid addiction better than referrals

April 28, 2015
Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more ...

Treat patients with addiction during, after hospitalization, researchers say

June 30, 2014
The results of a new study demonstrate that starting hospitalized patients who have an opioid (heroin) addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment ...

Clinical trial looks at tramadol for opioid withdrawal

July 12, 2017
A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential ...

For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

October 20, 2014
For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the ...

Why are doctors underusing a drug to treat opioid addiction?

August 3, 2017
A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding ...

Recommended for you

Research finds opioids may help chronic pain, a little

December 18, 2018
Use of opioids for patients with chronic, non-cancer pain may help, but not a lot.

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Early physical therapy can reduce risk, amount of long-term opioid use, study finds

December 14, 2018
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new ...

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.